Apollo Therapeutics
Latest round
- Series C
Last raised
- Dec 2023
Total raised
- $400M
Investors
- 5
About Apollo Therapeutics
Based in Cambridge, UK, and founded in 2016, Apollo Therapeutics is a biopharmaceutical company that develops therapies for rare diseases. The company's CEO, Dr. Richard Mason, CSO, Dr. Richard Butt, CFO, Jamie Heath, and CBO, Arjun Krishnan.72 million post-money. Apollo Therapeutics provides transformative treatments and de-risked pipeline in oncology, major inflammatory disorders and rare disease.
Who invested in Apollo Therapeutics
5 investors across 3 rounds
See all investors in Apollo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apollo Therapeutics
Who invested in Apollo Therapeutics?
Apollo Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apollo Therapeutics raised?
Apollo Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Apollo Therapeutics last raise money?
Apollo Therapeutics's most recent round on record is a Series C, in Dec 2023.
What does Apollo Therapeutics do?
Based in Cambridge, UK, and founded in 2016, Apollo Therapeutics is a biopharmaceutical company that develops therapies for rare diseases.
Where is Apollo Therapeutics headquartered?
Apollo Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like Apollo Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Apollo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Apollo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.